| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | methenyltetrahydrofolate cyclohydrolase activity | 4.13e-08 | 3 | 70 | 3 | GO:0004477 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase (NAD+) activity | 4.13e-08 | 3 | 70 | 3 | GO:0004487 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 1.65e-07 | 4 | 70 | 3 | GO:0004486 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 1.65e-07 | 4 | 70 | 3 | GO:0004488 | |
| GeneOntologyMolecularFunction | cyclohydrolase activity | 4.11e-07 | 5 | 70 | 3 | GO:0019238 | |
| GeneOntologyMolecularFunction | NADPH-hemoprotein reductase activity | 4.11e-07 | 5 | 70 | 3 | GO:0003958 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor | 8.87e-06 | 12 | 70 | 3 | GO:0016653 | |
| GeneOntologyMolecularFunction | FMN binding | 2.24e-05 | 16 | 70 | 3 | GO:0010181 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 3.24e-05 | 18 | 70 | 3 | GO:0016646 | |
| GeneOntologyMolecularFunction | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication | 1.20e-04 | 5 | 70 | 2 | GO:0086083 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors | 1.57e-04 | 30 | 70 | 3 | GO:0016645 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acetyltransferase activity | 1.80e-04 | 6 | 70 | 2 | GO:0003985 | |
| GeneOntologyMolecularFunction | C-acetyltransferase activity | 2.52e-04 | 7 | 70 | 2 | GO:0016453 | |
| GeneOntologyMolecularFunction | acetyl-CoA C-acyltransferase activity | 2.52e-04 | 7 | 70 | 2 | GO:0003988 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 2.71e-04 | 36 | 70 | 3 | GO:0016814 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 3.47e-04 | 95 | 70 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | chondroitin sulfate binding | 6.53e-04 | 11 | 70 | 2 | GO:0035374 | |
| GeneOntologyMolecularFunction | NADP binding | 1.35e-03 | 62 | 70 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 1.73e-03 | 146 | 70 | 4 | GO:0016810 | |
| GeneOntologyMolecularFunction | protein binding involved in heterotypic cell-cell adhesion | 1.79e-03 | 18 | 70 | 2 | GO:0086080 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 2.44e-03 | 21 | 70 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | mRNA binding | 2.89e-03 | 694 | 70 | 8 | GO:0003729 | |
| GeneOntologyMolecularFunction | NADPH binding | 3.73e-03 | 26 | 70 | 2 | GO:0070402 | |
| GeneOntologyBiologicalProcess | folic acid-containing compound metabolic process | 5.53e-06 | 34 | 71 | 4 | GO:0006760 | |
| GeneOntologyBiologicalProcess | methionine biosynthetic process | 8.41e-06 | 12 | 71 | 3 | GO:0009086 | |
| GeneOntologyBiologicalProcess | pteridine-containing compound metabolic process | 1.07e-05 | 40 | 71 | 4 | GO:0042558 | |
| GeneOntologyBiologicalProcess | L-histidine biosynthetic process | 1.17e-05 | 2 | 71 | 2 | GO:0000105 | |
| GeneOntologyBiologicalProcess | tetrahydrofolate interconversion | 2.12e-05 | 16 | 71 | 3 | GO:0035999 | |
| GeneOntologyBiologicalProcess | methionine metabolic process | 2.12e-05 | 16 | 71 | 3 | GO:0006555 | |
| GeneOntologyBiologicalProcess | folic acid metabolic process | 3.07e-05 | 18 | 71 | 3 | GO:0046655 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 4.97e-05 | 21 | 71 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | aspartate family amino acid biosynthetic process | 5.74e-05 | 22 | 71 | 3 | GO:0009067 | |
| GeneOntologyBiologicalProcess | tetrahydrofolate metabolic process | 6.59e-05 | 23 | 71 | 3 | GO:0046653 | |
| GeneOntologyBiologicalProcess | 10-formyltetrahydrofolate metabolic process | 1.74e-04 | 6 | 71 | 2 | GO:0009256 | |
| GeneOntologyBiologicalProcess | bundle of His cell-Purkinje myocyte adhesion involved in cell communication | 1.74e-04 | 6 | 71 | 2 | GO:0086073 | |
| GeneOntologyBiologicalProcess | aromatic amino acid family biosynthetic process | 1.74e-04 | 6 | 71 | 2 | GO:0009073 | |
| GeneOntologyBiologicalProcess | negative regulation of interferon-alpha production | 2.43e-04 | 7 | 71 | 2 | GO:0032687 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell-cardiac muscle cell adhesion | 2.43e-04 | 7 | 71 | 2 | GO:0086042 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 3.52e-04 | 40 | 71 | 3 | GO:0000096 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 4.06e-04 | 280 | 71 | 6 | GO:0006164 | |
| GeneOntologyBiologicalProcess | one-carbon metabolic process | 4.68e-04 | 44 | 71 | 3 | GO:0006730 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 4.71e-04 | 288 | 71 | 6 | GO:0072522 | |
| GeneOntologyBiologicalProcess | L-histidine metabolic process | 5.16e-04 | 10 | 71 | 2 | GO:0006547 | |
| GeneOntologyBiologicalProcess | desmosome organization | 5.16e-04 | 10 | 71 | 2 | GO:0002934 | |
| GeneOntologyBiologicalProcess | negative regulation of fibroblast proliferation | 5.34e-04 | 46 | 71 | 3 | GO:0048147 | |
| Domain | THF_DHG_CYH_1 | 5.04e-08 | 3 | 70 | 3 | PS00766 | |
| Domain | THF_DHG_CYH_2 | 5.04e-08 | 3 | 70 | 3 | PS00767 | |
| Domain | THF_DH/CycHdrlase_CS | 5.04e-08 | 3 | 70 | 3 | IPR020867 | |
| Domain | THF_DHG_CYH | 2.01e-07 | 4 | 70 | 3 | PF00763 | |
| Domain | THF_DH/CycHdrlase | 2.01e-07 | 4 | 70 | 3 | IPR000672 | |
| Domain | THF_DHG_CYH_C | 2.01e-07 | 4 | 70 | 3 | PF02882 | |
| Domain | THF_DH/CycHdrlase_cat_dom | 2.01e-07 | 4 | 70 | 3 | IPR020630 | |
| Domain | THF_DH/CycHdrlase_NAD-bd_dom | 2.01e-07 | 4 | 70 | 3 | IPR020631 | |
| Domain | FAD_binding_1 | 1.00e-06 | 6 | 70 | 3 | PF00667 | |
| Domain | FAD-binding_1 | 1.00e-06 | 6 | 70 | 3 | IPR003097 | |
| Domain | - | 1.00e-06 | 6 | 70 | 3 | 1.20.990.10 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 1.00e-06 | 6 | 70 | 3 | IPR023173 | |
| Domain | FLAVODOXIN_LIKE | 2.79e-06 | 8 | 70 | 3 | PS50902 | |
| Domain | Flavodoxin/NO_synth | 2.79e-06 | 8 | 70 | 3 | IPR008254 | |
| Domain | Flavdoxin-like | 2.79e-06 | 8 | 70 | 3 | IPR001094 | |
| Domain | Flavodoxin_1 | 2.79e-06 | 8 | 70 | 3 | PF00258 | |
| Domain | Flavoprotein-like_dom | 5.94e-06 | 10 | 70 | 3 | IPR029039 | |
| Domain | Flavoprot_Pyr_Nucl_cyt_Rdtase | 5.94e-06 | 10 | 70 | 3 | IPR001709 | |
| Domain | - | 5.94e-06 | 10 | 70 | 3 | 3.40.50.360 | |
| Domain | OxRdtase_FAD/NAD-bd | 1.08e-05 | 12 | 70 | 3 | IPR001433 | |
| Domain | NAD_binding_1 | 1.08e-05 | 12 | 70 | 3 | PF00175 | |
| Domain | Fd_Rdtase_FAD-bd | 4.68e-05 | 19 | 70 | 3 | IPR017927 | |
| Domain | FAD_FR | 4.68e-05 | 19 | 70 | 3 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 4.68e-05 | 19 | 70 | 3 | IPR017938 | |
| Domain | Thiolase_AS | 1.37e-04 | 5 | 70 | 2 | IPR020610 | |
| Domain | Thiolase_C | 2.06e-04 | 6 | 70 | 2 | PF02803 | |
| Domain | Thiolase_N | 2.06e-04 | 6 | 70 | 2 | PF00108 | |
| Domain | THIOLASE_2 | 2.06e-04 | 6 | 70 | 2 | PS00737 | |
| Domain | THIOLASE_1 | 2.06e-04 | 6 | 70 | 2 | PS00098 | |
| Domain | THIOLASE_3 | 2.06e-04 | 6 | 70 | 2 | PS00099 | |
| Domain | Thiolase_N | 2.06e-04 | 6 | 70 | 2 | IPR020616 | |
| Domain | Thiolase_C | 2.06e-04 | 6 | 70 | 2 | IPR020617 | |
| Domain | Thiolase_CS | 2.06e-04 | 6 | 70 | 2 | IPR020613 | |
| Domain | Thiolase | 2.06e-04 | 6 | 70 | 2 | IPR002155 | |
| Domain | - | 6.11e-04 | 10 | 70 | 2 | 3.40.47.10 | |
| Domain | Thiolase-like | 6.11e-04 | 10 | 70 | 2 | IPR016039 | |
| Domain | Fib_collagen_C | 7.45e-04 | 11 | 70 | 2 | IPR000885 | |
| Domain | COLFI | 7.45e-04 | 11 | 70 | 2 | PF01410 | |
| Domain | NC1_FIB | 7.45e-04 | 11 | 70 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 7.45e-04 | 11 | 70 | 2 | PD002078 | |
| Domain | COLFI | 7.45e-04 | 11 | 70 | 2 | SM00038 | |
| Domain | Collagen | 4.00e-03 | 85 | 70 | 3 | IPR008160 | |
| Domain | Collagen | 4.00e-03 | 85 | 70 | 3 | PF01391 | |
| Domain | - | 4.57e-03 | 27 | 70 | 2 | 1.10.260.40 | |
| Domain | AT_hook | 4.57e-03 | 27 | 70 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 4.57e-03 | 27 | 70 | 2 | IPR017956 | |
| Domain | Lambda_DNA-bd_dom | 5.27e-03 | 29 | 70 | 2 | IPR010982 | |
| Pathway | KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM | 3.21e-05 | 16 | 56 | 3 | M5244 | |
| Pathway | KEGG_ONE_CARBON_POOL_BY_FOLATE | 3.88e-05 | 17 | 56 | 3 | M12039 | |
| Pathway | REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES | 3.88e-05 | 17 | 56 | 3 | M27085 | |
| Pathway | WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT | 5.50e-05 | 19 | 56 | 3 | M39777 | |
| Pathway | REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES | 7.51e-05 | 21 | 56 | 3 | MM14763 | |
| Pathway | WP_FOLATE_METABOLISM | 1.59e-04 | 69 | 56 | 4 | M39617 | |
| Pathway | WP_ONECARBON_METABOLISM | 2.02e-04 | 29 | 56 | 3 | M39471 | |
| Pathway | WP_ONECARBON_METABOLISM | 3.26e-04 | 34 | 56 | 3 | MM15859 | |
| Pubmed | 3.26e-08 | 4 | 71 | 3 | 24733394 | ||
| Pubmed | Liver and brain differential expression of one-carbon metabolism genes during ontogenesis. | 6.24e-07 | 33 | 71 | 4 | 34702858 | |
| Pubmed | 8.38e-07 | 653 | 71 | 10 | 22586326 | ||
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 1.83e-06 | 282 | 71 | 7 | 35007762 | |
| Pubmed | 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. | 2.92e-06 | 14 | 71 | 3 | 19493349 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GMPS FBXO22 PNPLA6 GATAD2A ACAT2 DSP MTHFD1 DLAT AKAP13 ACAA2 SRBD1 SNRPA AQR | 3.14e-06 | 1353 | 71 | 13 | 29467282 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HOXA13 GATAD2A DSP DACH1 RBM15B CSTF3 KMT2A GIGYF2 SNRPA HSPA2 SF1 | 3.56e-06 | 954 | 71 | 11 | 36373674 |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 15342116 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 17854671 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 24589657 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 2587219 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 35894196 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 21397041 | ||
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 4.11e-06 | 2 | 71 | 2 | 15213259 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 28734943 | ||
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 4.11e-06 | 2 | 71 | 2 | 15703275 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 30150416 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 25544792 | ||
| Pubmed | AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner. | 4.11e-06 | 2 | 71 | 2 | 16061630 | |
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 4.11e-06 | 2 | 71 | 2 | 12230981 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12061812 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 11110714 | ||
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 4.11e-06 | 2 | 71 | 2 | 27644106 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GMPS SMAP1 FBXO22 GATAD2A DSP MTHFD1 UGGT1 DLAT GIGYF2 AKAP13 SNRPA SF1 AQR | 5.10e-06 | 1415 | 71 | 13 | 28515276 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.95e-06 | 497 | 71 | 8 | 36774506 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PNPLA6 GATAD2A DSG2 DSP MTHFD1 UGGT1 RBM15B SRBD1 SNRPA SF1 AQR PHC2 | 8.42e-06 | 1257 | 71 | 12 | 36526897 |
| Pubmed | 8.73e-06 | 1049 | 71 | 11 | 27880917 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SMAP1 HNF1A ACAT2 DSP MTHFD1 PTPRS MTHFD2 UGGT1 CSTF3 AKAP13 FRYL SNRPA | 1.04e-05 | 1284 | 71 | 12 | 17353931 |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 31099277 | ||
| Pubmed | NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis. | 1.23e-05 | 3 | 71 | 2 | 27889185 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 29392422 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 19948730 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 18195096 | ||
| Pubmed | MTHFD 1958G>A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia. | 1.23e-05 | 3 | 71 | 2 | 17417062 | |
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 18596851 | ||
| Pubmed | One-carbon metabolism enzyme polymorphisms and uteroplacental insufficiency. | 1.23e-05 | 3 | 71 | 2 | 18771981 | |
| Pubmed | GMPS HOXA13 GATAD2A MTHFD1 DACH1 CSTF3 KMT2A C15orf39 SNRPA SF1 CSTF2T | 1.39e-05 | 1103 | 71 | 11 | 34189442 | |
| Pubmed | 1.67e-05 | 551 | 71 | 8 | 34728620 | ||
| Pubmed | 1.74e-05 | 75 | 71 | 4 | 20571754 | ||
| Pubmed | 1.88e-05 | 1139 | 71 | 11 | 36417873 | ||
| Pubmed | Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. | 2.46e-05 | 4 | 71 | 2 | 25042803 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 16367885 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 18632414 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 20386493 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 16303847 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 8858175 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 20215590 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 23381804 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 20525856 | ||
| Pubmed | Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. | 2.46e-05 | 4 | 71 | 2 | 20447924 | |
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 20209990 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 2.53e-05 | 283 | 71 | 6 | 28533407 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.78e-05 | 774 | 71 | 9 | 15302935 | |
| Pubmed | 2.87e-05 | 29 | 71 | 3 | 19048631 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DSG2 DSP MTHFD1 UGGT1 RBM15B CSTF3 POR DLAT GIGYF2 SNRPA SF1 AQR | 2.92e-05 | 1425 | 71 | 12 | 30948266 |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 22781308 | ||
| Pubmed | Maintenance of neural stem cell positional identity by mixed-lineage leukemia 1. | 4.09e-05 | 5 | 71 | 2 | 32241942 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 14632302 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 20864495 | ||
| Pubmed | Folate and choline metabolism gene variants and development of uterine cervical carcinoma. | 4.09e-05 | 5 | 71 | 2 | 21349258 | |
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 20031617 | ||
| Pubmed | The cell adhesion molecule Sdk1 shapes assembly of a retinal circuit that detects localized edges. | 4.09e-05 | 5 | 71 | 2 | 34545809 | |
| Pubmed | Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. | 4.09e-05 | 5 | 71 | 2 | 19863551 | |
| Pubmed | Prognostic significance of folate metabolism polymorphisms for lung cancer. | 4.09e-05 | 5 | 71 | 2 | 17533396 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 4.25e-05 | 1024 | 71 | 10 | 24711643 | |
| Pubmed | Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. | 4.66e-05 | 34 | 71 | 3 | 20581827 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 4.78e-05 | 639 | 71 | 8 | 23443559 | |
| Pubmed | 5.09e-05 | 35 | 71 | 3 | 18992148 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 5.33e-05 | 197 | 71 | 5 | 29872149 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 5.45e-05 | 477 | 71 | 7 | 31300519 | |
| Pubmed | 5.58e-05 | 847 | 71 | 9 | 35850772 | ||
| Pubmed | 6.00e-05 | 202 | 71 | 5 | 24639526 | ||
| Pubmed | 6.05e-05 | 331 | 71 | 6 | 20634891 | ||
| Pubmed | GMPS FBXO22 DSG2 DSP MTHFD1 UGGT1 AKAP13 CHID1 SNRPA NDUFB6 AQR | 6.11e-05 | 1297 | 71 | 11 | 33545068 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 30687002 | ||
| Pubmed | Reporter-nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents. | 6.13e-05 | 6 | 71 | 2 | 29440485 | |
| Pubmed | Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma. | 6.13e-05 | 6 | 71 | 2 | 21055808 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 19112534 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 18296638 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 20394740 | ||
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 20056620 | ||
| Pubmed | E-cadherin and plakoglobin recruit plakophilin3 to the cell border to initiate desmosome assembly. | 6.13e-05 | 6 | 71 | 2 | 20859650 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 19533788 | ||
| Pubmed | 6.21e-05 | 859 | 71 | 9 | 31536960 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.32e-05 | 861 | 71 | 9 | 36931259 | |
| Pubmed | 7.34e-05 | 878 | 71 | 9 | 37223481 | ||
| Pubmed | 7.84e-05 | 686 | 71 | 8 | 28380382 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 NDOR1 PNPLA6 ZNF628 PTPRS C15orf39 AKAP13 FRYL IRS1 PHC2 | 8.01e-05 | 1105 | 71 | 10 | 35748872 |
| Pubmed | The Long Noncoding RNA Pnky Is a Trans-acting Regulator of Cortical Development In Vivo. | 8.57e-05 | 7 | 71 | 2 | 31112699 | |
| Pubmed | Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis. | 8.57e-05 | 7 | 71 | 2 | 36098964 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 15797993 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 19706844 | ||
| Pubmed | Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. | 8.57e-05 | 7 | 71 | 2 | 15479741 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.06e-04 | 922 | 71 | 9 | 27609421 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | 1.10e-04 | 926 | 71 | 9 | 20877624 | |
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 1.14e-04 | 8 | 71 | 2 | 28826662 | |
| Pubmed | Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. | 1.14e-04 | 8 | 71 | 2 | 19020309 | |
| Pubmed | Genome-wide association study reveals two new risk loci for bipolar disorder. | 1.14e-04 | 8 | 71 | 2 | 24618891 | |
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 31537781 | ||
| Pubmed | Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. | 1.14e-04 | 8 | 71 | 2 | 9864371 | |
| Interaction | RYR3 interactions | 1.42e-06 | 24 | 71 | 4 | int:RYR3 | |
| Interaction | PAPOLA interactions | 1.82e-05 | 92 | 71 | 5 | int:PAPOLA | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.35e-04 | 797 | 71 | 7 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q23 | 1.10e-03 | 130 | 71 | 3 | chr14q23 | |
| Cytoband | 15q24.2 | 1.14e-03 | 32 | 71 | 2 | 15q24.2 | |
| Cytoband | 9q32 | 2.44e-03 | 47 | 71 | 2 | 9q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q32 | 2.75e-03 | 50 | 71 | 2 | chr9q32 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 1.00e-06 | 503 | 71 | 10 | M2226 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 1.93e-06 | 541 | 71 | 10 | MM1061 | |
| Coexpression | WU_ALZHEIMER_DISEASE_DN | 1.79e-05 | 19 | 71 | 3 | M13334 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 4.29e-05 | 475 | 71 | 8 | M40979 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CACNA1B HOXA13 COL5A2 COL24A1 ABCA1 DSG2 DSP DACH1 CSTF3 GIGYF2 AKAP13 | 4.62e-05 | 769 | 71 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_200 | 5.27e-05 | 22 | 71 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | PCED1B TUBGCP6 ZSWIM8 NDOR1 ZNF628 ANK3 MTHFD2 DUSP9 RBM15B MTHFD2L C15orf39 SNRPA RBM20 SF1 | 6.16e-05 | 1259 | 71 | 14 | facebase_RNAseq_e9.5_MandArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 6.30e-05 | 407 | 71 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CACNA1B HOXA13 ABCA1 GATAD2A ANK3 DSG2 DSP PTPRS DACH1 C15orf39 ARMH4 | 8.04e-05 | 818 | 71 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 4.07e-06 | 149 | 71 | 5 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-06 | 163 | 71 | 5 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | CTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 8.65e-06 | 174 | 71 | 5 | ff4315e9fad198cc323fc987deb8652da137cf98 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-06 | 174 | 71 | 5 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-05 | 184 | 71 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-05 | 189 | 71 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.43e-05 | 193 | 71 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-HSC-MPP|bone_marrow / Manually curated celltypes from each tissue | 1.46e-05 | 194 | 71 | 5 | 3a7e7acbddc63da44d9a04a5b52adf6934fc83dd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 195 | 71 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 195 | 71 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.54e-05 | 196 | 71 | 5 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 196 | 71 | 5 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.58e-05 | 197 | 71 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.65e-05 | 199 | 71 | 5 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 1.65e-05 | 199 | 71 | 5 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | CTRL-Lymphoid-pDC|CTRL / Disease state, Lineage and Cell class | 7.22e-05 | 139 | 71 | 4 | bbc10812b0c5b8c85e78171c12316becde8895c3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|lymph-node_spleen / Manually curated celltypes from each tissue | 9.45e-05 | 149 | 71 | 4 | 32b0a8789d3be4889821afab0b52214deeff7e4d | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 157 | 71 | 4 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.21e-04 | 159 | 71 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-6|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.30e-04 | 162 | 71 | 4 | 0e8fb83acb8ea9905cc3ca985feb8a00931549ff | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 164 | 71 | 4 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.37e-04 | 164 | 71 | 4 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 164 | 71 | 4 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 1.40e-04 | 165 | 71 | 4 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 166 | 71 | 4 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 166 | 71 | 4 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 167 | 71 | 4 | e0f2509e86302eca8352821bce12597f6c51fc24 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 167 | 71 | 4 | b25646b6653cd8814dbeae4c74ce899ede105200 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 1.50e-04 | 168 | 71 | 4 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.50e-04 | 168 | 71 | 4 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-04 | 168 | 71 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 1.53e-04 | 169 | 71 | 4 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-04 | 169 | 71 | 4 | d0c64ca31053dfc283a07d5ad1117ca7dc1777a7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-04 | 169 | 71 | 4 | d79abfbeffd082a4fbffbc1051ffc474374874fa | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 170 | 71 | 4 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 1.57e-04 | 170 | 71 | 4 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 170 | 71 | 4 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 171 | 71 | 4 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 1.64e-04 | 172 | 71 | 4 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 172 | 71 | 4 | ddecdb1a0791296929790f78b49008f51a130f8b | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 1.64e-04 | 172 | 71 | 4 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 173 | 71 | 4 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 173 | 71 | 4 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-04 | 173 | 71 | 4 | 7a3115e7cf7e2f345192cde0656a7f0193594a5f | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 173 | 71 | 4 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.72e-04 | 174 | 71 | 4 | ab654e87c7eab7f33adc61be7a86da5c4d88008d | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.72e-04 | 174 | 71 | 4 | d9bccff5258c4277bdd1edbd87e17c327ec125e8 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.72e-04 | 174 | 71 | 4 | 2453419842fd22d066631615403393bfe4449bb8 | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.75e-04 | 175 | 71 | 4 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-04 | 175 | 71 | 4 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 175 | 71 | 4 | 6d5bdfbe53608e01c3845ecd908ca6d0fecc58f8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-04 | 175 | 71 | 4 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 175 | 71 | 4 | 6839ee3bb4457d13cb08ca8eb79ae33ddd256783 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-04 | 175 | 71 | 4 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 175 | 71 | 4 | 9d6135e183179968555670abec39dff9da2c3219 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group,lineage and cell class (2021.01.30) | 1.79e-04 | 176 | 71 | 4 | baa3563973ea1a351fe028f55828463d2a51bf1a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 176 | 71 | 4 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-04 | 176 | 71 | 4 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 177 | 71 | 4 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease state, Lineage and Cell class | 1.83e-04 | 177 | 71 | 4 | 3940663bb5b45b2ca9f772550380a516c53e410b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | a25ca82c4bda033ee113f8ecb4a541b22e7a29ca | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | fbead6e56271b1f1d447f89857de444ebe7157b0 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 177 | 71 | 4 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 177 | 71 | 4 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Control-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.83e-04 | 177 | 71 | 4 | e82115bfc32c7b689460fbc5caeb983c1aabe30f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 177 | 71 | 4 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | Control-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.87e-04 | 178 | 71 | 4 | 20ef63d925e67ddd5955832312ca8574a6f838a4 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 178 | 71 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_MORN2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.87e-04 | 178 | 71 | 4 | b0fc56f583cb3f2977fe2306994c0d478c9a6b1b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 179 | 71 | 4 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 179 | 71 | 4 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.95e-04 | 180 | 71 | 4 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 180 | 71 | 4 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.95e-04 | 180 | 71 | 4 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.95e-04 | 180 | 71 | 4 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 180 | 71 | 4 | 0c5d9245b8a7cc34ad52522d31559906cda55bdf | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-04 | 181 | 71 | 4 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 181 | 71 | 4 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 181 | 71 | 4 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 1.99e-04 | 181 | 71 | 4 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-04 | 181 | 71 | 4 | bec917f6f56ae252639a5a76024be5df5c70a6d5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 181 | 71 | 4 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.04e-04 | 182 | 71 | 4 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 2.04e-04 | 182 | 71 | 4 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 2.04e-04 | 182 | 71 | 4 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-04 | 182 | 71 | 4 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.04e-04 | 182 | 71 | 4 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-04 | 182 | 71 | 4 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-04 | 182 | 71 | 4 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.04e-04 | 182 | 71 | 4 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.08e-04 | 183 | 71 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 2.08e-04 | 183 | 71 | 4 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-04 | 183 | 71 | 4 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.12e-04 | 184 | 71 | 4 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.12e-04 | 184 | 71 | 4 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 187 | 71 | 4 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | CF-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 2.26e-04 | 187 | 71 | 4 | adc79e5804ab98006dbdf1d76ef0d8f85cc5cb0f | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-04 | 188 | 71 | 4 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| Disease | Neural tube defects, folate-sensitive | 3.22e-05 | 4 | 69 | 2 | cv:C1866558 | |
| Disease | Neural tube defect, folate-sensitive | 3.22e-05 | 4 | 69 | 2 | C1866558 | |
| Disease | NEURAL TUBE DEFECTS, FOLATE-SENSITIVE | 3.22e-05 | 4 | 69 | 2 | 601634 | |
| Disease | smoking status measurement, Cannabis use, schizophrenia | 4.28e-05 | 29 | 69 | 3 | EFO_0006527, EFO_0007585, MONDO_0005090 | |
| Disease | glutamate measurement | 4.28e-05 | 29 | 69 | 3 | EFO_0010487 | |
| Disease | spina bifida (is_implicated_in) | 8.03e-05 | 6 | 69 | 2 | DOID:0080016 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 8.72e-05 | 99 | 69 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | blood urea nitrogen measurement | 8.99e-05 | 452 | 69 | 7 | EFO_0004741 | |
| Disease | coronary artery disease (is_implicated_in) | 9.07e-05 | 100 | 69 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 9.79e-05 | 102 | 69 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | creatinine measurement | HOXA13 HNF1A FBXO22 DUSP9 DACH1 POR ARHGEF18 GIGYF2 NLRC3 PHC2 | 1.02e-04 | 995 | 69 | 10 | EFO_0004518 |
| Disease | Arrhythmogenic right ventricular cardiomyopathy | 1.12e-04 | 7 | 69 | 2 | cv:C0349788 | |
| Disease | premature menopause (biomarker_via_orthology) | 1.50e-04 | 8 | 69 | 2 | DOID:10787 (biomarker_via_orthology) | |
| Disease | saturated fatty acids measurement | 1.62e-04 | 45 | 69 | 3 | EFO_0022304 | |
| Disease | Cardiomyopathy | 1.84e-04 | 47 | 69 | 3 | cv:C0878544 | |
| Disease | triglycerides in HDL measurement | 2.64e-04 | 53 | 69 | 3 | EFO_0022317 | |
| Disease | Peripheral Nervous System Diseases | 2.79e-04 | 54 | 69 | 3 | C4721453 | |
| Disease | triglycerides in very large HDL measurement | 2.94e-04 | 55 | 69 | 3 | EFO_0022324 | |
| Disease | factor VII measurement | 2.94e-04 | 55 | 69 | 3 | EFO_0004619 | |
| Disease | anxiety disorder, stress-related disorder | 3.50e-04 | 12 | 69 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 3.81e-04 | 60 | 69 | 3 | EFO_0022282 | |
| Disease | Cannabis use | 6.33e-04 | 16 | 69 | 2 | EFO_0007585 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 7.16e-04 | 17 | 69 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 7.16e-04 | 17 | 69 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 9.39e-04 | 321 | 69 | 5 | EFO_0004612, EFO_0004639 | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.05e-03 | 85 | 69 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.06e-03 | 330 | 69 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 1.10e-03 | 21 | 69 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 1.10e-03 | 21 | 69 | 2 | OBA_2045156 | |
| Disease | lipid measurement, lipoprotein measurement | 1.24e-03 | 90 | 69 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | Coronary heart disease | 1.44e-03 | 24 | 69 | 2 | C0010068 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 1.69e-03 | 26 | 69 | 2 | EFO_0009944 | |
| Disease | azoospermia (implicated_via_orthology) | 1.82e-03 | 27 | 69 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | TYPE 2 DIABETES MELLITUS | 1.96e-03 | 28 | 69 | 2 | 125853 | |
| Disease | Type 2 diabetes mellitus | 1.96e-03 | 28 | 69 | 2 | cv:C0011860 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.10e-03 | 108 | 69 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | Primary familial dilated cardiomyopathy | 2.25e-03 | 30 | 69 | 2 | cv:C0340427 | |
| Disease | triacylglycerol 50:4 measurement | 2.25e-03 | 30 | 69 | 2 | EFO_0010411 | |
| Disease | ceramide measurement | 2.26e-03 | 235 | 69 | 4 | EFO_0010222 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.27e-03 | 111 | 69 | 3 | EFO_0004530, EFO_0008595 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGTTPGPLGRIVEFM | 461 | Q68DN1 | |
| VTPPSVVGGLGVTMV | 136 | P55087 | |
| GPVEPFSIVTMPGPR | 476 | Q8NFU1 | |
| PAGPGTQLGPITGEM | 361 | Q6ZSZ5 | |
| EGPRVSMLPSGVGPE | 1176 | Q6ZSZ5 | |
| DPGPSVVGLVSIPGM | 396 | Q9UHX3 | |
| VLGSPVTPPGIMVGE | 556 | Q86TY3 | |
| VTPPGIMVGEPSISP | 561 | Q86TY3 | |
| GGPPVVFLDEPTTGM | 2061 | O95477 | |
| VTDPQGVGTPEMIPL | 1141 | Q12802 | |
| PGLTMVVGPPGTGKT | 816 | O60306 | |
| GLMSPGIIPPTGLTA | 311 | Q9UI36 | |
| PVMLTGPLGEATVVP | 1081 | Q00975 | |
| MPLPGVFGGIGDPVT | 16 | O15263 | |
| PSGLGTEGMPTVEPG | 801 | Q8NDT2 | |
| GVMPQTPGQPAVILG | 201 | Q5T481 | |
| VTGSTMPPTTVILGP | 941 | Q14126 | |
| MRVTPEPGAGPTQGL | 46 | Q86YP4 | |
| LGIVTPGIVVTPMGS | 146 | Q8NEZ5 | |
| PVPFVPQVLGVMIGA | 51 | Q8IY17 | |
| TPVIMVGPGTGVAPF | 526 | P16435 | |
| VPPRVSITIGVAGMG | 136 | Q7RTR2 | |
| EEGPVPRTGAKGPIM | 126 | A6NK44 | |
| GEGVPVPPSLAGIMQ | 121 | Q96FN5 | |
| PSIPIIMVGPGTGIA | 536 | Q9UBK8 | |
| PLSLGIETAGGVMTP | 401 | P54652 | |
| GMAPVPTGVFTDIPI | 411 | P10515 | |
| MPVGEEVTGGFLPPK | 166 | Q96HM7 | |
| PGDTILETGEVIPPM | 106 | O95139 | |
| PGGVFPVPPAAVVLM | 606 | Q12996 | |
| GEPPMPTTGVILPSG | 466 | O94915 | |
| AGSSMAPVPGPVPVV | 146 | Q99956 | |
| ASLPGVMTIGPGEPA | 406 | P20823 | |
| VMTIGPGEPASLGPT | 411 | P20823 | |
| GPEMGGEQLGTVPLP | 76 | Q7L4E1 | |
| PVGPGAEPSVQTGMV | 901 | Q96RT7 | |
| VNVPVPVLIGPISGM | 1191 | Q7Z3U7 | |
| ESTGVEMGRLGPAPP | 956 | P35568 | |
| PETPDTPVIMVGPGT | 446 | Q9UHB4 | |
| TPVIMVGPGTGVAPF | 451 | Q9UHB4 | |
| GPGMVSVVGPMGLLV | 6 | Q13332 | |
| GIPGIPGIPGTTVMG | 201 | Q92838 | |
| MTGIPATPGNEIPVE | 646 | P49915 | |
| TLRPVETPVVGAPGM | 461 | Q6Y7W6 | |
| GTRVGTPGMIVPPPT | 176 | Q8TAL5 | |
| TGPGGVDMLVPSVGL | 496 | P15924 | |
| ITMTIPVPPPSGEGV | 1216 | Q12955 | |
| SQVGLMPGSVGPVGP | 206 | P05997 | |
| EMGGLGILTSVPITP | 1416 | Q03164 | |
| GMPGVGPVPLERGQV | 291 | Q9H0L4 | |
| GTPETMAPTIVVPPG | 286 | Q7Z5N4 | |
| PGPPMGILFPEVRTT | 1301 | Q58EX2 | |
| SFITPVPGGVGPMTV | 266 | P11586 | |
| VIPPAITPGTDQLGM | 226 | Q9BWS9 | |
| VPGPPGSLMVGGLTE | 111 | Q9P2P1 | |
| TPVPGGVGPMTVAML | 306 | P13995 | |
| VVMVGAGISTPSGIP | 141 | Q9NTG7 | |
| RMTPPGGTLPGAEDV | 411 | P20265 | |
| DMPVVPGLGGPGESR | 251 | P31271 | |
| TSPVPGRTLMGVDPG | 531 | Q8N5C6 | |
| PGLPGVPVTTDAMPR | 626 | Q6ZRI6 | |
| IGETGPVGLPGEVGM | 851 | Q17RW2 | |
| GCDPSIMGIGPVPAI | 286 | P42765 | |
| IVTAMPGGLPVPTSP | 496 | Q8IXK0 | |
| PGMVPGSQVIIIAGP | 311 | Q96CK0 | |
| VTPPPKGGGDMAVVV | 251 | Q9Y2W6 | |
| VGVEPSIMGIGPIPA | 286 | Q9BWD1 | |
| GVPVPAAPGLIGNVM | 346 | Q8IYB5 | |
| AGFITPVPGGVGPMT | 316 | Q9H903 | |
| PVPGGVGPMTVAMLL | 321 | Q9H903 | |
| MPEGRGGPGTEPVTV | 1456 | A7E2V4 | |
| TVIPGMPTVIPPGLT | 31 | Q15637 | |
| TPVVGAVQGPVPGMP | 131 | P09012 | |
| TGVGPLPVVLFNGMP | 626 | Q9NYU2 | |
| QAMLEPGEVVVPGPV | 391 | Q6ZMS7 | |
| VVPAGAGPGVMTPQG | 1026 | Q5EBL2 | |
| PGSGMLSIRVIPDGP | 3771 | Q5THJ4 |